• Home
  • About IBT
    • IBT History
    • Management
    • Board of Directors
    • Advisory Board
    • Sustainability Policy
  • Pipeline
    • IBP-9414
    • IBP-1016
    • IBP-1118
    • IBP-1122
    • Expanded Access Policy for Investigational Drugs
  • Healthcare Professionals
  • Investors & Media
    • Shares
    • Share Issue
    • Ownership Structure
    • Corporate Governance
    • Calendar
    • Financial Reports
    • Press Releases
    • Investors & Media Contact
  • Contact Us
  • Career
IBT Logo IBT Logo
  • En
  • Sv
  • Home
  • About IBT
    • IBT History
    • Management
    • Board of Directors
    • Advisory Board
    • Sustainability Policy
  • Pipeline
    • IBP-9414
    • IBP-1016
    • IBP-1118
    • IBP-1122
    • Expanded Access Policy for Investigational Drugs
  • Healthcare Professionals
  • Investors & Media
    • Shares
    • Share Issue
    • Ownership Structure
    • Corporate Governance
    • Calendar
    • Financial Reports
    • Press Releases
    • Investors & Media Contact
  • Contact Us
  • Career

Press releases


IBT resolves on a rights issue
May 16, 2023

Read more here

 

 

 

 

 

 

 

 

 

 

 

 

Latest press releases

2026-09-21 09:00 FDA Grants Infant Bacterial Therapeutics AB’s Request for a Type B Pre-BLA Meeting
2026-09-18 10:40 NOMINATION COMMITTEE FOR INFANT BACTERIAL THERAPEUTICS AB (PUBL) FOR THE ANNUAL GENERAL MEETING 2027 Regulatory
2026-08-26 07:30 Infant Bacterial Therapeutics AB (publ) Interim report January 1 – June 30, 2026 Regulatory
2026-07-07 12:05 Infant Bacterial Therapeutics CFO Leaves the Company Regulatory
2026-05-07 17:15 Annual General Meeting of Infant Bacterial Therapeutics Regulatory
Contact | info@ibtherapeutics.com
© Copyright Infant Bacterial Therapeutics AB 2026
Cookie Policy Privacy Policy Terms of Use